Drugs / OC-007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05685953 | Feb 2023 → Mar 2024 | COVID-19 | Matti Sällberg | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OC-007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05685953 ↗ |
| Modality | Vaccine | “Plasmid DNA vaccine” NCT05685953 ↗ |
| Route | Intramuscular | “delivered intramuscularly” NCT05685953 ↗ |